THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA

Their core work

i-HD is a Belgium-based institute specializing in the governance, standardization, and interoperability of health data across Europe. They provide the frameworks and infrastructure that allow clinical data — from patient-reported outcomes to genomic records — to be shared, linked, and used safely across borders and institutions. Their work enables large-scale health data initiatives by ensuring data quality, regulatory compliance, and semantic interoperability, serving as a trusted intermediary between hospitals, regulators, pharma companies, and research consortia. They are particularly strong in medication data standardization (IDMP), patient outcome measurement, and federated data approaches that keep sensitive health information secure.

What they specialise in

How they've shifted over time

In their earlier H2020 projects (2017–2020), i-HD focused on foundational health data challenges: cross-border patient summaries, health record linkage, medication identification standards (IDMP), and disease-specific data governance for clinical trials. From 2020 onward, their work shifted decisively toward patient empowerment, outcome measurement infrastructure, and AI-readiness — with projects emphasizing common data models, patient-reported outcomes, federated learning, and value-based healthcare. This evolution reflects a maturation from building the plumbing of health data exchange to enabling what that data can actually deliver for patients and healthcare systems.

i-HD is moving toward becoming the go-to European authority on making real-world health data usable for AI, federated analytics, and value-based healthcare — expect them to seek projects combining data governance with machine learning applications.

How they like to work

i-HD operates exclusively as a specialist partner, never as coordinator, which signals they are valued for deep technical expertise rather than project management. With 301 unique partners across 31 countries, they function as a network hub — a trusted node that different consortia pull in when they need health data governance credibility. Their participation in both very large IMI-style projects (UNICOM at EUR 1.9M) and smaller focused efforts shows flexibility in consortium scale.

i-HD has collaborated with 301 unique partners across 31 countries, giving them one of the broadest health data networks in Europe. Their partnerships span university hospitals, pharma companies, regulatory bodies, and health IT providers — making them a connector across the entire health data ecosystem.

What sets them apart

i-HD occupies a rare niche: they are neither a technology vendor nor a clinical institution, but an independent institute focused entirely on how health data should be governed, standardized, and shared. This neutrality makes them a trusted partner for projects where competing commercial or institutional interests could create friction around data access. For consortium builders, i-HD brings instant credibility on GDPR compliance, FAIR data principles, and cross-border interoperability — the aspects that reviewers scrutinize and that most partners lack in-house.

Highlights from their portfolio

• UNICOM
  Their largest project by far (EUR 1.9M), focused on scaling global medicine identification standards (IDMP) — a massive regulatory harmonization effort with direct pharmaceutical industry impact.
• EU-PEARL
  A flagship patient-centric clinical trial platform (EUR 751K to i-HD) tackling platform trials with Bayesian statistics across multiple disease areas including depression and tuberculosis.
• H2O
  Health Outcomes Observatory — building the infrastructure for systematically collecting patient-reported outcomes across Europe, directly enabling value-based healthcare models.